CN Stock MarketDetailed Quotes

603367 Cisen Pharmaceutical

Watchlist

13.43
+0.15+1.13%

Not Open Jan 20 15:00 CST

6.08BMarket Cap11.50P/E (TTM)

Cisen Pharmaceutical Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

Assets

Current assets

Money funds

-34.49%606.84M

-9.57%705.85M

2.43%937.04M

-1.46%983.39M

27.37%926.36M

25.30%780.58M

15.13%914.85M

6.28%997.95M

54.71%727.3M

73.95%622.96M

Transactional financial assets

13.36%1.81B

-0.55%1.62B

8.34%1.72B

5.67%1.64B

-8.74%1.6B

-5.15%1.63B

2.16%1.59B

4.38%1.55B

1.75%1.75B

-5.08%1.71B

Notes receivable and accounts receivable

-0.75%978.95M

0.25%1.08B

-12.36%1.2B

2.11%1.21B

0.29%986.39M

7.51%1.08B

50.18%1.36B

27.11%1.19B

68.06%983.58M

65.30%1.01B

-Notes receivable

11.83%296M

-9.23%307.6M

-45.10%345.19M

0.16%473.45M

15.95%264.68M

13.01%338.89M

114.95%628.76M

10.67%472.71M

--228.27M

--299.86M

-Accounts receivable

-5.37%682.95M

4.57%777.07M

15.63%850.47M

3.40%740.5M

-4.45%721.71M

5.17%743.11M

19.42%735.51M

40.92%716.16M

29.05%755.31M

16.05%706.57M

Other receivables (including interest and dividends)

260.24%16.21M

-17.29%8.5M

-46.08%10.56M

-54.22%4.24M

-84.11%4.5M

-14.38%10.27M

4.04%19.59M

-18.47%9.25M

102.93%28.31M

-8.63%12M

-Other receivable

----

-17.29%8.5M

----

-14.38%10.27M

----

-18.47%9.25M

----

-8.63%12M

Advance payment

9.39%94.09M

-21.43%71.53M

23.70%126.6M

32.41%115.79M

-26.13%86.01M

-18.30%91.04M

28.73%102.34M

153.69%87.45M

84.03%116.43M

42.63%111.42M

Inventories

2.20%846.37M

4.13%793.37M

6.93%702.1M

22.01%708.22M

37.36%828.14M

23.67%761.91M

8.36%656.57M

-2.39%580.43M

-6.79%602.92M

-7.79%616.09M

Receivable financing

50.66%130.33M

19.04%99.58M

131.44%183.69M

79.69%148.85M

33.70%86.5M

198.08%83.65M

128.58%79.37M

-26.79%82.83M

-60.84%64.7M

-81.93%28.06M

Non-current assets due within one year

-23.57%133.3M

-31.61%132.19M

-58.41%134.22M

-64.82%83.12M

--174.41M

--193.29M

--322.75M

--236.27M

----

Other current assets

3,596.48%187.53M

1,810.13%215.3M

1,197.44%144.84M

512.40%74.61M

-44.75%5.07M

63.85%11.27M

-55.39%11.16M

-61.90%12.18M

-21.97%9.18M

-15.37%6.88M

Total current assets

2.34%4.81B

1.90%4.73B

1.90%5.15B

4.74%4.97B

9.61%4.7B

12.67%4.64B

25.80%5.06B

14.49%4.74B

16.48%4.28B

11.43%4.12B

Non Current assets

Other non-current financial assets

0.00%80K

-99.21%80K

Investment real estate

-2.68%4.9M

-2.66%4.94M

-2.64%4.97M

-2.63%5.01M

-2.61%5.04M

-3.05%5.07M

-3.54%5.11M

-4.02%5.14M

-4.49%5.18M

-4.50%5.23M

Long-term equity investment

-80.41%5.88M

-76.42%5.88M

-76.44%5.88M

-76.28%5.85M

19.27%30.01M

1.14%24.93M

1.69%24.95M

-3.51%24.67M

-36.75%25.16M

-43.54%24.65M

Fixed assets

----

-1.48%1.23B

----

-3.15%1.25B

----

-7.10%1.28B

----

-2.84%1.29B

Fixed assets liquidation

----

0.00%192.98K

----

--192.98K

----

--192.48K

----

Constru in process

----

115.51%316.73M

----

-32.85%146.97M

----

3.74%207.17M

----

-29.08%218.88M

Intangible assets

-1.06%205.52M

-0.96%207.89M

0.03%210.7M

-0.67%211.6M

1.16%207.72M

1.37%209.9M

0.86%210.64M

1.05%213.03M

-3.22%205.33M

1.35%207.05M

Long deferred expense

-91.43%361.93K

-62.08%1.63M

64.85%6.79M

-50.65%1.91M

-2.38%4.22M

65.03%4.29M

101.34%4.12M

88.79%3.86M

--4.32M

--2.6M

Deferred tax assets

-18.44%77.08M

18.82%109.02M

-16.09%73.97M

-7.95%79.83M

21.00%94.52M

10.78%91.75M

7.42%88.16M

6.20%86.72M

22.94%78.11M

32.93%82.83M

Usufruct assets

4,264.86%5.84M

1,019.86%6.35M

1,068.92%8.18M

854.85%7.38M

-98.74%133.87K

-95.03%567.42K

-94.18%700.09K

-94.00%772.51K

--10.67M

--11.41M

Other non current assets

22.55%761.08M

23.27%679.12M

88.65%639.98M

171.55%673.08M

93.58%621.04M

63.08%550.91M

-17.01%339.23M

-18.07%247.86M

-5.50%320.83M

-0.22%337.82M

Total non current assets

12.47%2.67B

12.21%2.56B

14.01%2.4B

14.39%2.37B

12.24%2.37B

4.75%2.28B

-7.98%2.11B

-6.72%2.07B

-6.08%2.12B

-5.23%2.18B

Total assets

5.74%7.48B

5.30%7.29B

5.46%7.56B

7.67%7.34B

10.48%7.07B

9.93%6.92B

13.54%7.17B

7.09%6.82B

7.91%6.4B

5.04%6.3B

Liabilities

Current liabilities

Short term loan

117.45%46.06M

83.49%75.95M

26.29%66.29M

-39.78%34.8M

-85.88%21.18M

-68.16%41.39M

-59.62%52.49M

-55.54%57.79M

15.38%150M

0.00%130M

Notes payable and accounts payable

21.22%595.16M

3.70%449.89M

21.24%492.91M

1.80%468.01M

5.51%490.97M

-6.42%433.85M

-5.18%406.56M

5.69%459.71M

9.81%465.35M

-19.56%463.62M

-Notes payable

200.00%120M

--40M

--27M

48.89%67M

-55.16%40M

----

--45M

197.33%89.2M

-38.27%45M

-Accounts payable

5.36%475.16M

-5.52%409.89M

14.60%465.91M

-3.30%401.01M

19.89%450.97M

3.64%433.85M

-5.18%406.56M

-4.66%414.71M

-4.48%376.15M

-16.86%418.62M

Contract liabilities

3.89%96.58M

6.00%85.7M

28.14%98.27M

-15.68%100.16M

62.95%92.96M

44.45%80.85M

15.65%76.69M

69.56%118.78M

-23.81%57.05M

-20.81%55.97M

Advance receipts

----

339,821.22%934.78K

----

--3.1M

--275

----

--275

----

Salaries payable

5.56%92.18M

9.61%87.7M

4.09%89.01M

-0.26%83.51M

0.25%87.33M

0.59%80.01M

15.60%85.51M

18.66%83.73M

50.45%87.1M

43.08%79.54M

Taxs payable

-17.76%26.89M

-19.39%39.02M

5.27%68.24M

5.23%91.25M

-56.95%32.7M

-19.93%48.41M

16.64%64.82M

13.05%86.71M

192.10%75.94M

104.99%60.46M

Other payable (including interest and dividends)

15.26%452.81M

16.53%386.26M

22.58%416.57M

44.21%284.46M

136.99%392.84M

130.50%331.46M

106.83%339.83M

5.99%197.25M

2.03%165.77M

-20.75%143.8M

-Dividend payable

7,369.59%99.61M

-25.66%1.98M

-19.81%1.33M

-52.54%1.33M

-5.26%2.66M

28.00%1.66M

116.26%2.81M

-Other payable

----

16.87%384.28M

----

133.20%328.8M

----

5.83%195.59M

----

-21.73%140.99M

Non current liabilities due within one year

2,095.33%3.34M

78,231.43%3.34M

710.50%2.43M

1,013.26%3.34M

-94.62%152.01K

-99.85%4.26K

-89.11%299.76K

-89.00%299.76K

--2.83M

--2.8M

Other current liabilities

38.87%191.29M

-14.20%200.74M

-56.91%191.14M

9.63%304.39M

123.68%137.75M

33.10%233.98M

192.47%443.55M

12.03%277.65M

684.45%61.58M

2,353.16%175.8M

Total current liabilities

19.78%1.5B

6.03%1.33B

-2.99%1.43B

6.86%1.37B

17.85%1.26B

12.69%1.25B

36.93%1.47B

5.17%1.28B

20.70%1.07B

5.83%1.11B

Current liabilities

Long term loan

-78.38%28M

-74.43%28M

28.50%128.5M

--129.5M

--109.5M

--100M

----

Deferred tax liabilities

-11.66%16.31M

81.14%37.94M

-79.18%3.37M

10.65%12.68M

506.88%18.46M

394.91%20.95M

436.11%16.18M

196.42%11.46M

-14.92%3.04M

24.29%4.23M

Long term deferred income

-6.10%55.02M

-14.21%52.2M

-28.31%45.36M

-13.93%56.25M

-11.82%58.59M

-10.36%60.84M

-11.15%63.27M

-12.19%65.36M

-9.50%66.44M

-5.63%67.87M

Lease liabilities

325.49%2.36M

270.87%2.93M

996.62%5.81M

687.20%4.03M

-93.93%554.41K

-90.59%790.71K

-95.03%529.57K

-95.30%512.22K

--9.13M

--8.4M

Other non current liabilities

----

--8.79M

----

Total non current liabilities

-50.90%101.68M

-36.97%121.07M

6.58%191.83M

13.61%201.46M

163.45%207.1M

138.60%192.08M

112.03%179.98M

98.79%177.33M

2.10%78.61M

6.88%80.5M

Total liabilities

9.77%1.61B

0.31%1.45B

-1.95%1.62B

7.68%1.57B

27.86%1.46B

21.19%1.45B

42.44%1.65B

11.55%1.46B

19.21%1.14B

5.90%1.19B

Shareholders equity

Paid-in capital

-0.11%452.76M

-0.11%452.78M

-0.12%452.78M

-0.01%453.25M

-0.01%453.26M

-0.02%453.26M

-0.00%453.31M

-0.01%453.31M

Capital reserve funds

0.26%1.93B

0.38%1.93B

0.35%1.92B

0.32%1.92B

1.61%1.92B

2.93%1.92B

2.80%1.92B

2.69%1.91B

2.65%1.89B

1.07%1.86B

Surplus reserve funds

0.00%226.68M

Retained profit

7.73%3.23B

11.48%3.2B

12.91%3.29B

13.38%3.13B

10.96%3B

10.73%2.87B

10.34%2.92B

8.41%2.76B

8.21%2.7B

8.33%2.6B

Less:Treasury stock

-99.58%81.41K

-99.59%81.41K

-40.83%19.27M

-40.60%19.35M

-40.91%19.35M

-39.62%19.77M

-35.49%32.57M

Other composite income

47.82%-3.35M

40.18%-2.24M

68.28%-925.37K

8.34%-2.69M

-115.62%-6.41M

0.64%-3.74M

-23.15%-2.92M

4.35%-2.93M

-14.99%-2.97M

-36.18%-3.77M

Shareholders equity without minority interests

4.64%5.84B

6.56%5.81B

7.36%5.9B

7.41%5.73B

6.42%5.58B

6.79%5.45B

6.57%5.49B

5.49%5.33B

5.46%5.24B

4.85%5.1B

Minority interests

14.36%33.43M

16.92%31.37M

76.69%44.56M

65.38%39.1M

109.02%29.23M

5,753.24%26.83M

6,665.19%25.22M

3,050.33%23.64M

1,543.72%13.98M

-48.97%458.36K

Total shareholder equity

4.69%5.87B

6.61%5.84B

7.68%5.94B

7.67%5.77B

6.70%5.61B

7.30%5.48B

7.05%5.52B

5.94%5.36B

5.73%5.26B

4.84%5.1B

Total liabilityies and equity

5.74%7.48B

5.30%7.29B

5.46%7.56B

7.67%7.34B

10.48%7.07B

9.93%6.92B

13.54%7.17B

7.09%6.82B

7.91%6.4B

5.04%6.3B

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Daxin Certified Public Accountants (Special General Partnership)

	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022
Assets
Current assets
Money funds	-34.49%606.84M	-9.57%705.85M	2.43%937.04M	-1.46%983.39M	27.37%926.36M	25.30%780.58M	15.13%914.85M	6.28%997.95M	54.71%727.3M	73.95%622.96M
Transactional financial assets	13.36%1.81B	-0.55%1.62B	8.34%1.72B	5.67%1.64B	-8.74%1.6B	-5.15%1.63B	2.16%1.59B	4.38%1.55B	1.75%1.75B	-5.08%1.71B
Notes receivable and accounts receivable	-0.75%978.95M	0.25%1.08B	-12.36%1.2B	2.11%1.21B	0.29%986.39M	7.51%1.08B	50.18%1.36B	27.11%1.19B	68.06%983.58M	65.30%1.01B
-Notes receivable	11.83%296M	-9.23%307.6M	-45.10%345.19M	0.16%473.45M	15.95%264.68M	13.01%338.89M	114.95%628.76M	10.67%472.71M	--228.27M	--299.86M
-Accounts receivable	-5.37%682.95M	4.57%777.07M	15.63%850.47M	3.40%740.5M	-4.45%721.71M	5.17%743.11M	19.42%735.51M	40.92%716.16M	29.05%755.31M	16.05%706.57M
Other receivables (including interest and dividends)	260.24%16.21M	-17.29%8.5M	-46.08%10.56M	-54.22%4.24M	-84.11%4.5M	-14.38%10.27M	4.04%19.59M	-18.47%9.25M	102.93%28.31M	-8.63%12M
-Other receivable	----	-17.29%8.5M	----	----	----	-14.38%10.27M	----	-18.47%9.25M	----	-8.63%12M
Advance payment	9.39%94.09M	-21.43%71.53M	23.70%126.6M	32.41%115.79M	-26.13%86.01M	-18.30%91.04M	28.73%102.34M	153.69%87.45M	84.03%116.43M	42.63%111.42M
Inventories	2.20%846.37M	4.13%793.37M	6.93%702.1M	22.01%708.22M	37.36%828.14M	23.67%761.91M	8.36%656.57M	-2.39%580.43M	-6.79%602.92M	-7.79%616.09M
Receivable financing	50.66%130.33M	19.04%99.58M	131.44%183.69M	79.69%148.85M	33.70%86.5M	198.08%83.65M	128.58%79.37M	-26.79%82.83M	-60.84%64.7M	-81.93%28.06M
Non-current assets due within one year	-23.57%133.3M	-31.61%132.19M	-58.41%134.22M	-64.82%83.12M	--174.41M	--193.29M	--322.75M	--236.27M	----	----
Other current assets	3,596.48%187.53M	1,810.13%215.3M	1,197.44%144.84M	512.40%74.61M	-44.75%5.07M	63.85%11.27M	-55.39%11.16M	-61.90%12.18M	-21.97%9.18M	-15.37%6.88M
Total current assets	2.34%4.81B	1.90%4.73B	1.90%5.15B	4.74%4.97B	9.61%4.7B	12.67%4.64B	25.80%5.06B	14.49%4.74B	16.48%4.28B	11.43%4.12B
Non Current assets
Other non-current financial assets	0.00%80K	0.00%80K	0.00%80K	0.00%80K	0.00%80K	0.00%80K	0.00%80K	0.00%80K	0.00%80K	-99.21%80K
Investment real estate	-2.68%4.9M	-2.66%4.94M	-2.64%4.97M	-2.63%5.01M	-2.61%5.04M	-3.05%5.07M	-3.54%5.11M	-4.02%5.14M	-4.49%5.18M	-4.50%5.23M
Long-term equity investment	-80.41%5.88M	-76.42%5.88M	-76.44%5.88M	-76.28%5.85M	19.27%30.01M	1.14%24.93M	1.69%24.95M	-3.51%24.67M	-36.75%25.16M	-43.54%24.65M
Fixed assets	----	-1.48%1.23B	----	----	----	-3.15%1.25B	----	-7.10%1.28B	----	-2.84%1.29B
Fixed assets liquidation	----	0.00%192.98K	----	----	----	--192.98K	----	--192.48K	----	----
Constru in process	----	115.51%316.73M	----	----	----	-32.85%146.97M	----	3.74%207.17M	----	-29.08%218.88M
Intangible assets	-1.06%205.52M	-0.96%207.89M	0.03%210.7M	-0.67%211.6M	1.16%207.72M	1.37%209.9M	0.86%210.64M	1.05%213.03M	-3.22%205.33M	1.35%207.05M
Long deferred expense	-91.43%361.93K	-62.08%1.63M	64.85%6.79M	-50.65%1.91M	-2.38%4.22M	65.03%4.29M	101.34%4.12M	88.79%3.86M	--4.32M	--2.6M
Deferred tax assets	-18.44%77.08M	18.82%109.02M	-16.09%73.97M	-7.95%79.83M	21.00%94.52M	10.78%91.75M	7.42%88.16M	6.20%86.72M	22.94%78.11M	32.93%82.83M
Usufruct assets	4,264.86%5.84M	1,019.86%6.35M	1,068.92%8.18M	854.85%7.38M	-98.74%133.87K	-95.03%567.42K	-94.18%700.09K	-94.00%772.51K	--10.67M	--11.41M
Other non current assets	22.55%761.08M	23.27%679.12M	88.65%639.98M	171.55%673.08M	93.58%621.04M	63.08%550.91M	-17.01%339.23M	-18.07%247.86M	-5.50%320.83M	-0.22%337.82M
Total non current assets	12.47%2.67B	12.21%2.56B	14.01%2.4B	14.39%2.37B	12.24%2.37B	4.75%2.28B	-7.98%2.11B	-6.72%2.07B	-6.08%2.12B	-5.23%2.18B
Total assets	5.74%7.48B	5.30%7.29B	5.46%7.56B	7.67%7.34B	10.48%7.07B	9.93%6.92B	13.54%7.17B	7.09%6.82B	7.91%6.4B	5.04%6.3B
Liabilities
Current liabilities
Short term loan	117.45%46.06M	83.49%75.95M	26.29%66.29M	-39.78%34.8M	-85.88%21.18M	-68.16%41.39M	-59.62%52.49M	-55.54%57.79M	15.38%150M	0.00%130M
Notes payable and accounts payable	21.22%595.16M	3.70%449.89M	21.24%492.91M	1.80%468.01M	5.51%490.97M	-6.42%433.85M	-5.18%406.56M	5.69%459.71M	9.81%465.35M	-19.56%463.62M
-Notes payable	200.00%120M	--40M	--27M	48.89%67M	-55.16%40M	----	----	--45M	197.33%89.2M	-38.27%45M
-Accounts payable	5.36%475.16M	-5.52%409.89M	14.60%465.91M	-3.30%401.01M	19.89%450.97M	3.64%433.85M	-5.18%406.56M	-4.66%414.71M	-4.48%376.15M	-16.86%418.62M
Contract liabilities	3.89%96.58M	6.00%85.7M	28.14%98.27M	-15.68%100.16M	62.95%92.96M	44.45%80.85M	15.65%76.69M	69.56%118.78M	-23.81%57.05M	-20.81%55.97M
Advance receipts	----	----	339,821.22%934.78K	----	----	--3.1M	--275	----	--275	----
Salaries payable	5.56%92.18M	9.61%87.7M	4.09%89.01M	-0.26%83.51M	0.25%87.33M	0.59%80.01M	15.60%85.51M	18.66%83.73M	50.45%87.1M	43.08%79.54M
Taxs payable	-17.76%26.89M	-19.39%39.02M	5.27%68.24M	5.23%91.25M	-56.95%32.7M	-19.93%48.41M	16.64%64.82M	13.05%86.71M	192.10%75.94M	104.99%60.46M
Other payable (including interest and dividends)	15.26%452.81M	16.53%386.26M	22.58%416.57M	44.21%284.46M	136.99%392.84M	130.50%331.46M	106.83%339.83M	5.99%197.25M	2.03%165.77M	-20.75%143.8M
-Dividend payable	7,369.59%99.61M	-25.66%1.98M	-19.81%1.33M	-19.81%1.33M	-52.54%1.33M	-5.26%2.66M	28.00%1.66M	28.00%1.66M	116.26%2.81M	116.26%2.81M
-Other payable	----	16.87%384.28M	----	----	----	133.20%328.8M	----	5.83%195.59M	----	-21.73%140.99M
Non current liabilities due within one year	2,095.33%3.34M	78,231.43%3.34M	710.50%2.43M	1,013.26%3.34M	-94.62%152.01K	-99.85%4.26K	-89.11%299.76K	-89.00%299.76K	--2.83M	--2.8M
Other current liabilities	38.87%191.29M	-14.20%200.74M	-56.91%191.14M	9.63%304.39M	123.68%137.75M	33.10%233.98M	192.47%443.55M	12.03%277.65M	684.45%61.58M	2,353.16%175.8M
Total current liabilities	19.78%1.5B	6.03%1.33B	-2.99%1.43B	6.86%1.37B	17.85%1.26B	12.69%1.25B	36.93%1.47B	5.17%1.28B	20.70%1.07B	5.83%1.11B
Current liabilities
Long term loan	-78.38%28M	-74.43%28M	28.50%128.5M	28.50%128.5M	--129.5M	--109.5M	--100M	--100M	----	----
Deferred tax liabilities	-11.66%16.31M	81.14%37.94M	-79.18%3.37M	10.65%12.68M	506.88%18.46M	394.91%20.95M	436.11%16.18M	196.42%11.46M	-14.92%3.04M	24.29%4.23M
Long term deferred income	-6.10%55.02M	-14.21%52.2M	-28.31%45.36M	-13.93%56.25M	-11.82%58.59M	-10.36%60.84M	-11.15%63.27M	-12.19%65.36M	-9.50%66.44M	-5.63%67.87M
Lease liabilities	325.49%2.36M	270.87%2.93M	996.62%5.81M	687.20%4.03M	-93.93%554.41K	-90.59%790.71K	-95.03%529.57K	-95.30%512.22K	--9.13M	--8.4M
Other non current liabilities	----	----	--8.79M	----	----	----	----	----	----	----
Total non current liabilities	-50.90%101.68M	-36.97%121.07M	6.58%191.83M	13.61%201.46M	163.45%207.1M	138.60%192.08M	112.03%179.98M	98.79%177.33M	2.10%78.61M	6.88%80.5M
Total liabilities	9.77%1.61B	0.31%1.45B	-1.95%1.62B	7.68%1.57B	27.86%1.46B	21.19%1.45B	42.44%1.65B	11.55%1.46B	19.21%1.14B	5.90%1.19B
Shareholders equity
Paid-in capital	-0.11%452.76M	-0.11%452.78M	-0.11%452.78M	-0.12%452.78M	-0.01%453.25M	-0.01%453.26M	-0.02%453.26M	-0.00%453.31M	-0.01%453.31M	-0.01%453.31M
Capital reserve funds	0.26%1.93B	0.38%1.93B	0.35%1.92B	0.32%1.92B	1.61%1.92B	2.93%1.92B	2.80%1.92B	2.69%1.91B	2.65%1.89B	1.07%1.86B
Surplus reserve funds	0.00%226.68M	0.00%226.68M	0.00%226.68M	0.00%226.68M	0.00%226.68M	0.00%226.68M	0.00%226.68M	0.00%226.68M	0.00%226.68M	0.00%226.68M
Retained profit	7.73%3.23B	11.48%3.2B	12.91%3.29B	13.38%3.13B	10.96%3B	10.73%2.87B	10.34%2.92B	8.41%2.76B	8.21%2.7B	8.33%2.6B
Less:Treasury stock	-99.58%81.41K	-99.58%81.41K	-99.58%81.41K	-99.59%81.41K	-40.83%19.27M	-40.60%19.35M	-40.91%19.35M	-39.62%19.77M	-35.49%32.57M	-35.49%32.57M
Other composite income	47.82%-3.35M	40.18%-2.24M	68.28%-925.37K	8.34%-2.69M	-115.62%-6.41M	0.64%-3.74M	-23.15%-2.92M	4.35%-2.93M	-14.99%-2.97M	-36.18%-3.77M
Shareholders equity without minority interests	4.64%5.84B	6.56%5.81B	7.36%5.9B	7.41%5.73B	6.42%5.58B	6.79%5.45B	6.57%5.49B	5.49%5.33B	5.46%5.24B	4.85%5.1B
Minority interests	14.36%33.43M	16.92%31.37M	76.69%44.56M	65.38%39.1M	109.02%29.23M	5,753.24%26.83M	6,665.19%25.22M	3,050.33%23.64M	1,543.72%13.98M	-48.97%458.36K
Total shareholder equity	4.69%5.87B	6.61%5.84B	7.68%5.94B	7.67%5.77B	6.70%5.61B	7.30%5.48B	7.05%5.52B	5.94%5.36B	5.73%5.26B	4.84%5.1B
Total liabilityies and equity	5.74%7.48B	5.30%7.29B	5.46%7.56B	7.67%7.34B	10.48%7.07B	9.93%6.92B	13.54%7.17B	7.09%6.82B	7.91%6.4B	5.04%6.3B
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	--	Unqualified opinion	--	--	--	Unqualified opinion	--	--
Auditor	--	--	--	Daxin Certified Public Accountants (Special General Partnership)	--	--	--	Daxin Certified Public Accountants (Special General Partnership)	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List

Overall

No Data

603367 Cisen Pharmaceutical

Cisen Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow